cimicoxib
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Zusammenfassung Im Jahr 2017 kam für Kleintiere mit Lokivetmab (Cytopoint®), einem kaninisierten monoklonalen Antikörper gegen…
BackgroundCaesarean section of bitches is a well recognized painful condition in dogs and it can be classified as a soft tissue…
Cimicoxib (CX) is a new non-steroidal anti-inflammatory drug from the "coxib" family, designed for dogs. In the available…
Background: Cimicoxib is a coxib recently
licensed in Europe for pain and inflammation associated with osteoarthritis
(OA), and…
Objectives To determine the efficacy and safety of cimicoxib (Cimalgex®; Vétoquinol SA) for the control of perioperative pain in…
Objective: To synthesize cimicoxib.Methods: Cimicoxib was synthesized from 4-(acetylamino)phenylsulfonyl chloride via six steps…
The synthesis and pharmacological evaluation of new water-soluble phosphoramidate derivatives of the COX-2 selective inhibitor…
The discovery of an inducible form of cyclooxygenase (COX) stimulated the search for new, isolom-selective inhibitors that…